Epilepsy & Seizures
News
Potential New Treatment for Photosensitive Epilepsy
Wednesday, April 10, 2019—Results of a phase 2a study (NCT02564029) published in Neurology show that CVL-865 (Cerevel Therapeutics, LLC, Boston, MA) has anticonvulsant activity in patients wi…
Trofinetide Phase 2 Study Shows Safety and Clinically Relevant Improvement for Rett’s Syndrome
Wednesday, March 27, 2019—Positive results from a phase 2 randomized, placebo-controlled clinical trial (NCT02715115) of trofinetide (Acadia Pharmaceuticals, San Diego, CA; Neuren Pharmaceuticals, Melb…
Gene Delivery Into Ependymal Cells Lining Ventricles for Batten’s Disease
Monday, March 25, 2019—As genetic therapy for neurologic diseases moves toward the mainstream, a key challenge that must be addressed is the need to deliver genes to the central nervous system (CNS)…
The Importance of Sleep
Logan Schneider, MD
March/April 2019—Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.
Dizziness and Vertigo
Ari A. Shemesh, MD; and Daniel R. Gold, DO
March/April 2019—Part 1: Untangling the complexity of dizziness and vertigo requires a careful history.
Epilepsy Foundation Promotes Proper First Aid for Seizures
Tuesday, March 05, 2019—The Epilepsy Foundation has launched a series of public service announcements (PSAs) in an initiative to improve about seizure recognition and awareness of proper first aid.&n…
Expanded Access to Free Genetic Testing for Children with Epilepsy
Wednesday, February 27, 2019—Eligibility for a program that provides free genetic testing for epilepsy in young children has been expanded. The Behind the Seizure program, which had been available for pat…
Scalp Neurostimulation Reduces Seizure Activity in Drug-Resistant Epilepsy
Tuesday, February 26, 2019—A device that uses mild electrical currents on the scalp achieved positive results for treating patients with drug-resistant epilepsy. In an investigational study (NCT02866240…
